首页|功能性便秘患者述情障碍发生情况及其对疗效的影响

功能性便秘患者述情障碍发生情况及其对疗效的影响

扫码查看
目的 探讨功能性便秘(FC)患者述情障碍发生情况及其对患者便秘症状、肛门直肠功能和治疗效果的影响.方法 选择2022年7月4日至2023年9月30日在南京医科大学第一附属医院消化内科门诊就诊并行高分辨率肛门直肠测压(HR-ARM)的FC患者118例.将多伦多述情障碍量表总分<51分判定为无述情障碍,总分≥51分判定为有述情障碍.应用渗透性泻剂联合益生菌制剂进行治疗,疗程为4周.比较有无述情障碍FC患者治疗前后及两者治疗后的药物治疗效果,以及便秘症状自评量表(PAC-SYM)、便秘生活质量自评量表(PAC-QoL)、焦虑自评量表(SAS)、抑郁自评量表(SDS)评分和HR-ARM检测指标.采用独立样本t检验、Mann-Whitney U检验和卡方检验进行统计学分析.采用多因素logistic回归分析FC药物疗效的相关影响因素.结果43.2%(51/118)的FC患者有述情障碍,56.8%(67/118)无述情障碍,无述情障碍和有述情障碍患者中分别有43、32例完成治疗效果评估.有述情障碍FC患者治疗前后周均完全自发性排便次数比较,差异无统计学意义(P>0.05).无述情障碍FC患者治疗后周均完全自发性排便次数高于治疗前[5.0(3.0,7.0)次比3.0(2.0,3.0)次],有述情障碍患者治疗后周均完全自发性排便次数较治疗前的增高程度劣于无述情障碍患者[0.0(0.0,0.0)次比-2.0(-3.0,0.0)次],差异均有统计学意义(Z=-4.49、-3.79,均P<0.001).无述情障碍FC患者治疗后PAC-SYM、PAC-QoL、SAS、SDS评分均低于治疗前[分别为2.0(0.0,8.0)分比14.0(11.0,16.0)分、9.0(1.1,16.0)分比 22.0(18.0,40.0)分、26.0(25.0,30.0)分比 29.0(25.0,34.0)分、28.0(26.0,30.0)分比 30.0(29.0,35.0)分],差异均有统计学意义(Z=-5.24、-5.08、-3.60、-5.21,均P<0.001).有述情障碍FC患者治疗后仅PAC-SYM评分低于治疗前[14.0(9.5,19.0)分比17.0(12.5,21.0)分],差异有统计学意义(Z=-2.66,P=0.008).无述情障碍FC患者的治疗有效率高于有述情障碍患者[72.1%(31/43)比18.8%(6/32)],差异有统计学意义(x2=22.09,P<0.001).有述情障碍FC患者治疗后PAC-SYM、PAC-QoL、SAS、SDS评分的降低程度均劣于无述情障碍患者[分别为0.0(0.0,2.8)分比9.0(2.0,14.0)分、0.0(0.0,0.8)分比 15.0(2.0,19.0)分、0.0(-1.0,1.0)分比0.0(0.0,4.0)分、0.0(0.0,1.0)分比 3.0(1.0,5.0)分],差异均有统计学意义(Z=-4.24、-4.31、-2.59、-4.60,均P<0.05).多因素logistic回归分析显示,述情障碍是FC患者便秘药物治疗无效的独立危险因素(OR=8.930,95%置信区间2.011~39.658,P=0.004).结论FC患者中述情障碍有较高发生率,述情障碍影响FC患者症状感知及便秘药物治疗效果.
The occurrence of alexithymia in patients with functional constipation and its influence on the therapeutic efficacy
Objective To explore the occurrence of alexithymia in patients with functional constipation(FC)and its influence on the symptoms,anorectal function and treatment efficacy.Methods From July 4,2022 to September 30,2023,a total of 118 FC patients who visited the outpatient Department of Gastroenterology,the First Affiliated Hospital of Nanjing Medical University and underwent high-resolution anorectal manometry(HR-ARM)were selected.According to twenty-item Toronto alexithymia scale,a total score of<51 was classified as without alexithymia,and a total score of ≥51 was classified as with alexithymia.The combination of osmotic laxatives and probiotic agents was used for the treatment for 4 weeks.The efficacy of the medication was compared before and after treatment in FC patients with and without alexithymia,as well as the scores of patient assessment of constipation-symptom(PAC-SYM),patient assessment of constipation-quality of life(PAC-QoL),self-rating anxiety scale(SAS),self-rating depression scale(SDS)and HR-ARM results.Independent sample t-test,Mann-Whitney U test and chi-square test were used for statistical analysis.Multivariate logistic regression analysis was performed to analyze the related factors affecting the efficacy of FC treatment.Results Among the 118 FC patients,43.2%(51/118)of FC patients had alexithymia,and 56.8%(67/118)of FC patients had no alexithymia.Among them,43 patients without alexithymia and 32 patients with alexithymia completed the evaluation of treatment efficacy,respectively.There was no statistically significant difference in the frequency of spontaneous defecation before and after treatment in patients with alexithymia(P>0.05).The frequency of complete spontaneous defecation after treatment was higher than that before treatment in FC patients without alexithymia(5.0(3.0,7.0)vs.3.0(2.0,3.0)),and the increased times of total spontaneous defecation after treatment compared to before treatment in patients with alexithymia was less than that in patients without alexithymia(0.0(0.0,0.0)vs.-2.0(-3.0,0.0)),and the differences were statistically significant(Z=-4.49 and-3.79,both P<0.001).The scores of PAC-SYM,PAC-QoL,SAS and SDS in FC patients without alexithymia after treatment were all lower than those before treatment(2.0(0.0,8.0)vs.14.0(11.0,16.0),9.0(1.1,16.0)vs.22.0(18.0,40.0),26.0(25.0,30.0)vs.29.0(25.0,34.0),28.0(26.0,30.0)vs.30.0(29.0,35.0)),and the differences were statistically significant(Z=-5.24,-5.08,-3.60,and-5.21,all P<0.001).Among all the scores,only the PAC-SYM score after treatment was lower than that before treatment in FC patients with alexithymia(14.0(9.5,19.0)vs.17.0(12.5,21.0)),and the difference was statistically significant(Z=-2.66,P=0.008).The effective rate of FC patients without alexithymia was higher than that of patients with alexithymia(72.1%,31/43 vs.18.8%,6/32),and the difference was significant(x2=22.09,P<0.001).The reduction of PAC-SYM,PAC-QoL,SAS and SDS scores in FC patients with alexithymia after treatment were all lower than those of FC patients without alexithymia(0.0(0.0,2.8)vs.9.0(2.0,14.0),0.0(0.0,0.8)vs.15.0(2.0,19.0),0.0(-1.0,1.0)vs.0.0(0.0,4.0),0.0(0.0,1.0)vs.3.0(1.0,5.0)),and the differences were statistically significant(Z=-4.24,-4.31,-2.59,and-4.60,all P<0.05).The results of multivariate logistic regression analysis showed that alexithymia was an independent risk factor of ineffective medication treatment of constipation in FC patients(OR=8.930,95%confidence interval 2.011 to 39.658,P=0.004).Conclusions There is a high incidence of alexithymia in FC patients.Alexithymia affects the perception of symptoms and the efficacy of medication treatment of constipation in FC patients.

AlexithymiaFunctional constipationSymptomQuality of lifeEfficacy

施赛男、王美峰、林琳、姜柳琴

展开 >

南京医科大学第一附属医院消化内科,南京 210029

述情障碍 功能性便秘 症状 生活质量 疗效

2024

中华消化杂志
中华医学会

中华消化杂志

CSTPCD北大核心
影响因子:1.726
ISSN:0254-1432
年,卷(期):2024.44(8)